These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34427938)

  • 1. Lack of pharmacokinetic interaction between the HIV-1 maturation inhibitor GSK3640254 and combination oral contraceptives in healthy women.
    Pene Dumitrescu T; Greene TJ; Joshi SR; Xu J; Johnson M; Halliday F; Butcher L; Zimmerman E; Webster L; Pham TT; Lataillade M; Min S
    Br J Clin Pharmacol; 2022 Feb; 88(4):1704-1712. PubMed ID: 34427938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of effect of oral cabotegravir on the pharmacokinetics of a levonorgestrel/ethinyl oestradiol-containing oral contraceptive in healthy adult women.
    Trezza C; Ford SL; Gould E; Lou Y; Huang C; Ritter JM; Buchanan AM; Spreen W; Patel P
    Br J Clin Pharmacol; 2017 Jul; 83(7):1499-1505. PubMed ID: 28087972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of deliberate omission of Trinordiol or Microgynon on the hypothalamo-pituitary-ovarian axis.
    Smith SK; Kirkman RJ; Arce BB; McNeilly AS; Loudon NB; Baird DT
    Contraception; 1986 Nov; 34(5):513-22. PubMed ID: 3102162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Phase I Evaluation of the Pharmacokinetics and Tolerability of the HIV-1 Maturation Inhibitor GSK3640254 and Tenofovir Alafenamide/Emtricitabine in Healthy Participants.
    Pene Dumitrescu T; Joshi SR; Xu J; Zhan J; Johnson M; Butcher L; Zimmerman E; Webster L; Davidson AM; Lataillade M; Min S
    Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33753329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ticagrelor on the pharmacokinetics of ethinyl oestradiol and levonorgestrel in healthy volunteers.
    Butler K; Teng R
    Curr Med Res Opin; 2011 Aug; 27(8):1585-93. PubMed ID: 21692601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I evaluation of pharmacokinetics and tolerability of the HIV-1 maturation inhibitor GSK3640254 and dolutegravir in healthy adults.
    Pene Dumitrescu T; Joshi SR; Xu J; Greene TJ; Johnson M; Butcher L; Zimmerman E; Webster L; Pham TT; Lataillade M; Min S
    Br J Clin Pharmacol; 2021 Sep; 87(9):3501-3507. PubMed ID: 33533507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects.
    Sidhu J; Job S; Singh S; Philipson R
    Br J Clin Pharmacol; 2006 Feb; 61(2):191-9. PubMed ID: 16433873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamic and pharmacokinetic evaluation of coadministration of lacosamide and an oral contraceptive (levonorgestrel plus ethinylestradiol) in healthy female volunteers.
    Cawello W; Rosenkranz B; Schmid B; Wierich W
    Epilepsia; 2013 Mar; 54(3):530-6. PubMed ID: 23360419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ritonavir on the pharmacokinetics of ethinyl oestradiol in healthy female volunteers.
    Ouellet D; Hsu A; Qian J; Locke CS; Eason CJ; Cavanaugh JH; Leonard JM; Granneman GR
    Br J Clin Pharmacol; 1998 Aug; 46(2):111-6. PubMed ID: 9723818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of transdermal rotigotine on ovulation suppression by a combined oral contraceptive.
    Braun M; Elshoff JP; Andreas JO; Müller LI; Horstmann R
    Br J Clin Pharmacol; 2009 Sep; 68(3):386-94. PubMed ID: 19740396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Multi-Center, Open-Label, Pharmacokinetic Drug Interaction Study of Erenumab and a Combined Oral Contraceptive in Healthy Females.
    Xu Y; Gabriel K; Wang Y; Zhou Y; Eisele O; Vutikullird A; Mikol DD; Lee E
    CNS Drugs; 2019 May; 33(5):513-522. PubMed ID: 30963506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase 1, open-label study to evaluate the drug interaction between islatravir (MK-8591) and the oral contraceptive levonorgestrel/ethinyl estradiol in healthy adult females.
    Ankrom W; Jackson Rudd D; Zhang S; Fillgrove KL; Gravesande KN; Matthews RP; Brimhall D; Stoch SA; Iwamoto MN
    J Int AIDS Soc; 2021 Dec; 24(12):e25858. PubMed ID: 34935295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and pharmacodynamic interactions between the hepatitis C virus protease inhibitor, boceprevir, and the oral contraceptive ethinyl estradiol/norethindrone.
    Lin WH; Feng HP; Shadle CR; O'Reilly T; Wagner JA; Butterton JR
    Eur J Clin Pharmacol; 2014 Sep; 70(9):1107-13. PubMed ID: 24992979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
    Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Flibanserin on the Pharmacokinetics of a Combined Ethinylestradiol/Levonorgestrel Oral Contraceptive in Healthy Premenopausal Women: A Randomized Crossover Study.
    Johnson-Agbakwu C; Brown L; Yuan J; Kissling R; Greenblatt DJ
    Clin Ther; 2018 Jan; 40(1):64-73. PubMed ID: 29198449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An investigation into the effect of tenidap sodium on the pharmacokinetics of a combined oral contraceptive.
    Coates PE; Mesure R
    Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):47S-50S. PubMed ID: 7547095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No clinically relevant drug-drug interactions when dalcetrapib is co-administered with a monophasic oral contraceptive (Microgynon® 30).
    Young A; Anzures-Cabrera J; Derks M
    Int J Clin Pharmacol Ther; 2012 Apr; 50(4):248-56. PubMed ID: 22456295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of tolterodine on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive containing ethinyl estradiol and levonorgestrel.
    Olsson B; Landgren BM
    Clin Ther; 2001 Nov; 23(11):1876-88. PubMed ID: 11768839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of levonorgestrel and ethinylestradiol in 14 women during three months of treatment with a tri-step combination oral contraceptive: serum protein binding of levonorgestrel and influence of treatment on free and total testosterone levels in the serum.
    Kuhnz W; Staks T; Jütting G
    Contraception; 1994 Dec; 50(6):563-79. PubMed ID: 7705098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of empagliflozin on the steady-state pharmacokinetics of ethinylestradiol and levonorgestrel in healthy female volunteers.
    Macha S; Mattheus M; Pinnetti S; Woerle HJ; Broedl UC
    Clin Drug Investig; 2013 May; 33(5):351-7. PubMed ID: 23512637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.